Cambridge Epigenetix
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Epigenetics-focused company creating precision diagnostics through advanced genomic analysis of DNA modifications.
OncologyNeurology
Technology Platform
Proprietary sequencing and bioinformatics platform for high-resolution detection and analysis of epigenetic modifications, such as DNA methylation and hydroxymethylation.
Opportunities
Growing demand for non-invasive, early detection diagnostics in oncology could drive adoption of its epigenetic biomarker tests.
Risk Factors
Regulatory challenges and the need to prove clinical utility and cost-effectiveness in crowded diagnostic markets.
Competitive Landscape
Operates in the competitive epigenetics diagnostics space, competing with large sequencing companies and specialized epigenetics firms.